Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus | Zendy

Mônica Andrade Lima Gabbay | Zendy; Maria Notomi Sato | Zendy; Claudia Finazzo | Zendy; Alberto J. S. Duarte | Zendy; Sérgio Atala Dib | Zendy

Open Access

Effect of Cholecalciferol as Adjunctive Therapy With Insulin on Protective Immunologic Profile and Decline of Residual β-Cell Function in New-Onset Type 1 Diabetes Mellitus

Author(s) -

Mônica Andrade Lima Gabbay,

Maria Notomi Sato,

Claudia Finazzo,

Alberto J. S. Duarte,

Sérgio Atala Dib

Publication year - 2012

Publication title -

archives of pediatrics and adolescent medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3628

pISSN - 1072-4710

DOI - 10.1001/archpediatrics.2012.164

Subject(s) - cholecalciferol , medicine , vitamin d and neurology , endocrinology , insulin , placebo , vitamin , diabetes mellitus , gastroenterology , alternative medicine , pathology

To evaluate the effect of vitamin D3 on cytokine levels, regulatory T cells, and residual β-cell function decline when cholecalciferol (vitamin D3 administered therapeutically) is given as adjunctive therapy with insulin in new-onset type 1 diabetes mellitus (T1DM).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research